Novanta (NOVT) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChartTranscripts

Novanta Revenue Highlights


Latest Revenue (Y)

$949.25M

Latest Revenue (Q)

$241.05M

Main Segment (Y)

Advanced Surgery

Main Geography (Y)

UNITED STATES

Novanta Revenue by Period


Novanta Revenue by Year

DateRevenueChange
2024-12-31$949.25M7.67%
2023-12-31$881.66M2.41%
2022-12-31$860.90M21.80%
2021-12-31$706.79M19.67%
2020-12-31$590.62M-5.67%
2019-12-31$626.10M1.91%
2018-12-31$614.34M17.85%
2017-12-31$521.29M35.49%
2016-12-31$384.76M2.99%
2015-12-31$373.60M2.44%
2014-12-31$364.71M6.76%
2013-12-31$341.61M25.82%
2012-12-31$271.50M-25.88%
2011-12-31$366.28M-4.49%
2010-12-31$383.52M68.17%
2009-12-31$228.05M-20.94%
2008-12-31$288.47M-9.23%
2007-12-31$317.80M1.34%
2006-12-31$313.61M20.26%
2005-12-31$260.78M-20.98%
2004-12-31$330.01M77.85%
2003-12-31$185.56M16.65%
2002-12-31$159.07M-35.83%
2001-12-31$247.90M-33.69%
2000-12-31$373.86M36.15%
1999-12-31$274.60M90.43%
1998-12-31$144.20M-

Novanta generated $949.25M in revenue during NA 2024, up 7.67% compared to the previous quarter, and up 151.61% compared to the same period a year ago.

Novanta Revenue by Quarter

DateRevenueChange
2025-06-27$241.05M3.29%
2025-03-28$233.37M-1.97%
2024-12-31$238.06M-2.60%
2024-09-27$244.41M3.62%
2024-06-28$235.86M2.14%
2024-03-29$230.92M9.14%
2023-12-31$211.57M-4.48%
2023-09-29$221.50M-3.47%
2023-06-30$229.46M4.72%
2023-03-31$219.13M0.34%
2022-12-31$218.37M-2.06%
2022-09-30$222.96M3.53%
2022-07-01$215.36M5.46%
2022-04-01$204.22M2.64%
2021-12-31$198.96M11.95%
2021-10-01$177.73M6.09%
2021-07-02$167.52M3.04%
2021-04-02$162.58M10.23%
2020-12-31$147.50M3.20%
2020-10-02$142.93M-1.24%
2020-07-03$144.73M-6.91%
2020-04-03$155.47M-2.65%
2019-12-31$159.70M3.66%
2019-09-27$154.07M-0.70%
2019-06-28$155.15M-1.30%
2019-03-29$157.19M0.65%
2018-12-31$156.18M-2.87%
2018-09-28$160.79M6.91%
2018-06-29$150.40M2.34%
2018-03-30$146.97M0.03%
2017-12-31$146.92M0.43%
2017-09-29$146.30M22.83%
2017-06-30$119.10M9.29%
2017-03-31$108.97M10.21%
2016-12-31$98.88M1.07%
2016-09-30$97.83M0.10%
2016-07-01$97.73M8.21%
2016-04-01$90.32M0.11%
2015-12-31$90.22M-2.22%
2015-10-02$92.27M-4.38%
2015-07-03$96.49M1.99%
2015-04-03$94.61M0.64%
2014-12-31$94.01M-0.68%
2014-09-26$94.66M-2.32%
2014-06-27$96.91M22.46%
2014-03-28$79.13M-9.78%
2013-12-31$87.71M2.60%
2013-09-27$85.48M0.21%
2013-06-28$85.31M2.64%
2013-03-29$83.11M25.15%
2012-12-31$66.41M-4.47%
2012-09-28$69.52M-1.22%
2012-06-29$70.38M-10.69%
2012-03-30$78.81M-1.24%
2011-12-31$79.80M-14.44%
2011-09-30$93.26M-8.00%
2011-07-01$101.37M10.36%
2011-04-01$91.86M0.26%
2010-12-31$91.62M0.08%
2010-10-01$91.55M6.77%
2010-07-02$85.74M-25.20%
2010-04-02$114.61M58.07%
2009-12-31$72.51M-

Novanta generated $241.05M in revenue during Q2 2025, up 3.29% compared to the previous quarter, and up 104.39% compared to the same period a year ago.

Novanta Revenue Breakdown


Novanta Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23Dec 22Dec 21Dec 20
Advanced Surgery$208.75M----
Precision Manufacturing$202.30M----
Medical Solutions-$325.22M---
Vision--$277.99M$262.06M$261.65M
Photonics--$274.67M$232.46M$199.61M
Precision Motion--$308.24M$212.27M$129.36M

Novanta's latest annual revenue breakdown by segment (product or service), as of Dec 24: Advanced Surgery (50.78%), and Precision Manufacturing (49.22%).

Quarterly Revenue by Product

Product/ServiceJun 25Mar 25Sep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jul 22Apr 22Dec 21Oct 21Jul 21Apr 21Dec 20Oct 20Jul 20Apr 20
Robotics and Automation$77.83M$78.59M------------------
Precision Medicine$59.16M$54.01M------------------
Precision Manufacturing$43.84M$44.58M------------------
Advanced Surgery$60.22M$56.19M------------------
Medical Solutions--$103.78M$102.45M$80.88M$83.38M$83.32M$77.64M------------
Precision Motion--------$69.66M$78.81M$80.38M$79.38M$76.98M$57.12M$41.72M$36.45M$33.62M$32.24M$32.19M$31.32M
Photonics--------$71.63M$70.80M$69.46M$62.78M$56.35M$55.26M$62.36M$58.49M$50.28M$46.39M$47.80M$55.14M
Vision--------$77.08M$73.34M$65.52M$62.05M$65.63M$65.35M$63.45M$67.64M$63.60M$64.30M$64.74M$69.01M

Novanta's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Robotics and Automation (32.29%), Advanced Surgery (24.98%), Precision Medicine (24.54%), and Precision Manufacturing (18.19%).

Novanta Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 24Dec 23Dec 22Dec 21Dec 20
Rest Of Asia Pacific$107.05M$105.35M$101.60M$89.20M$74.33M
CHINA$84.56M$73.44M$97.18M$95.05M$70.56M
GERMANY$123.24M$128.23M$133.73M$101.86M$83.77M
Other Countries$18.40M$19.35M$18.25M$10.99M$9.17M
UNITED STATES$487.11M$418.26M$372.35M$270.83M$225.76M
Rest Of Europe$128.87M$137.03M$137.80M$138.86M$127.04M

Novanta's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (51.32%), Rest Of Europe (13.58%), GERMANY (12.98%), Rest Of Asia Pacific (11.28%), CHINA (8.91%), and Other Countries (1.94%).

Quarterly Revenue by Country

CountryJun 25Mar 25Dec 24Sep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jul 22Apr 22Dec 21Oct 21Jul 21Apr 21Dec 20Oct 20Jul 20
Rest Of Asia Pacific$24.67M$23.38M$27.32M$27.15M$27.26M$25.79M$24.06M$27.39M$28.11M$27.20M$26.89M$23.09M$22.84M$24.43M$21.26M$22.76M$20.75M$18.38M$16.41M$17.84M
Other Countries$4.38M$4.65M$5.20M$4.16M$5.36M$3.42M$3.78M$6.99M$5.15M$4.44M$4.01M$4.71M$6.71M$4.69M$1.79M$2.38M$2.12M$2.19M$2.10M$2.03M
GERMANY$27.26M$28.48M$24.59M$33.56M$33.18M$28.01M$33.26M$32.10M$34.86M$34.20M$34.63M$33.12M$31.78M$30.42M$23.77M$22.36M$19.50M$18.89M$22.15M-
CHINA$21.78M$21.43M$23.85M$24.62M$17.07M$19.11M$15.68M$20.85M$17.80M$16.30M$24.21M$29.87M$26.80M$26.76M$23.51M$22.55M$20.27M$17.41M$17.47M-
UNITED STATES$128.12M$123.65M$122.31M$124.33M$117.08M$96.37M$110.46M$107.59M$103.84M$103.76M$99.23M$86.65M$82.72M$79.13M$59.50M$59.23M$54.40M$57.63M$54.52M-
Rest Of Europe$34.85M$31.78M$34.79M$30.58M$30.97M$38.87M$34.26M$34.54M$29.36M$32.48M$34.00M$37.92M$33.37M$33.52M$34.16M$35.60M$35.58M$32.76M$30.48M$30.71M
C N--------------$22.23M-----
U S--------------$72.97M-----
D E--------------$25.31M-----

Novanta's latest quarterly revenue breakdown by geography, as of Jun 25: UNITED STATES (53.15%), Rest Of Europe (14.46%), GERMANY (11.31%), Rest Of Asia Pacific (10.23%), CHINA (9.03%), and Other Countries (1.82%).

Novanta Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
FTVFortive$6.23B$1.52B
STSensata Technologies$3.93B$943.38B
VNTVontier$2.98B$773.50M
ITRIItron$2.44B$606.76M
ESEESCO$1.03B$296.34M
NOVTNovanta$949.25M$241.05M
BMIBadger Meter$826.56M$238.09M
VPGVishay Precision Group$306.52M$75.16M
MLABMesa Laboratories$216.19M$59.54M
SOTKSono-Tek$19.70M$5.13M

NOVT Revenue FAQ


What is Novanta’s yearly revenue?

Novanta's yearly revenue for 2024 was $949.24M, representing an increase of 7.67% compared to 2023. The company's yearly revenue for 2023 was $881.66M, representing an increase of 2.41% compared to 2022. NOVT's yearly revenue for 2022 was $860.9M, representing an increase of 21.80% compared to 2021.

What is Novanta’s quarterly revenue?

Novanta's quarterly revenue for Q2 2025 was $241.05M, a 3.29% increase from the previous quarter (Q1 2025), and a 2.20% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $233.37M, a -1.97% decrease from the previous quarter (Q4 2024), and a 1.06% increase year-over-year (Q1 2024). NOVT's quarterly revenue for Q4 2024 was $238.06M, a -2.60% decrease from the previous quarter (Q3 2024), and a 12.52% increase year-over-year (Q4 2023).

What is Novanta’s revenue growth rate?

Novanta's revenue growth rate for the last 3 years (2022-2024) was 10.26%, and for the last 5 years (2020-2024) was 60.72%.

What are Novanta’s revenue streams?

Novanta's revenue streams in c 24 are Advanced Surgery, and Precision Manufacturing. Advanced Surgery generated $208.75M in revenue, accounting 50.78% of the company's total revenue Precision Manufacturing generated $202.3M in revenue, accounting 49.22% of the company's total revenue

What is Novanta’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Novanta was Advanced Surgery. This segment made a revenue of $208.75M, representing 50.78% of the company's total revenue.